Cardiovascular

Candalkan 4 & 8 & 16 mg
  • Active Substance (s) : Candesartan celexetil 4 mg, 8 mg and 16 mg
  • Dosage Form : Film Coated Tablets
  • Pack : 7 tablets/strip
  • Indication :
    • The treatment of primary hypertension in adults
    • The treatment of hypertension in children and adolescents aged 6 to 18 years
    • The treatment of adult patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction ≤ 40%) when Angiotensin Converting Enzyme (ACE)-inhibitors are not tolerated or as add-on therapy to ACE-inhibitors in patients with symptomatic heart failure, despite optimal therapy, when mineralocorticoid receptor antagonists are not tolerated
  • Product Description : Candalkan causes a dose-dependent, long-lasting reduction in arterial blood pressure. The antihypertensive action is due to decreased systemic peripheral resistance, without reflex increase in heart rate
  • Recommended Daily Dosage :
    • In Hypertension: Initial dose and usual maintenance dose of Candalkan is 8 mg once daily
    • In Heart Failure: Initial dose of Candalkan is 4 mg once daily
    • Up titration to the target dose of 32 mg once daily (maximum dose) or the highest tolerated dose is done by doubling the dose at intervals of at least 2 weeks